Severely Ill COVID-19 Patients Display Impaired Exhaustion Features in SARS-CoV-2-reactive CD8 T Cells
Overview
Authors
Affiliations
The molecular properties of CD8 T cells that respond to SARS-CoV-2 infection are not fully known. Here, we report on the single-cell transcriptomes of >80,000 virus-reactive CD8 T cells, obtained using a modified Antigen-Reactive T cell Enrichment (ARTE) assay, from 39 COVID-19 patients and 10 healthy subjects. COVID-19 patients segregated into two groups based on whether the dominant CD8 T cell response to SARS-CoV-2 was 'exhausted' or not. SARS-CoV-2-reactive cells in the exhausted subset were increased in frequency and displayed lesser cytotoxicity and inflammatory features in COVID-19 patients with mild compared to severe illness. In contrast, SARS-CoV-2-reactive cells in the dominant non-exhausted subset from patients with severe disease showed enrichment of transcripts linked to co-stimulation, pro-survival NF-κB signaling, and anti-apoptotic pathways, suggesting the generation of robust CD8 T cell memory responses in patients with severe COVID-19 illness. CD8 T cells reactive to influenza and respiratory syncytial virus from healthy subjects displayed polyfunctional features and enhanced glycolysis. Cells with such features were largely absent in SARS-CoV-2-reactive cells from both COVID-19 patients and healthy controls non-exposed to SARS-CoV-2. Overall, our single-cell analysis revealed substantial diversity in the nature of CD8 T cells responding to SARS-CoV-2.
Effector CD8 T cell differentiation in primary and breakthrough SARS-CoV-2 infection in mice.
Kingstad-Bakke B, Lee W, Yount Jr B, Cleven T, Park H, Sullivan J Commun Biol. 2025; 8(1):392.
PMID: 40057586 PMC: 11890755. DOI: 10.1038/s42003-025-07820-7.
Asaba C, Bitazar R, Labonte P, Bukong T PLoS One. 2025; 20(2):e0309880.
PMID: 39928675 PMC: 11809808. DOI: 10.1371/journal.pone.0309880.
Therapeutic plasma exchange accelerates immune cell recovery in severe COVID-19.
Guironnet-Paquet A, Hamzeh-Cognasse H, Berard F, Cognasse F, Richard J, Yonis H Front Immunol. 2025; 15:1492672.
PMID: 39896810 PMC: 11782122. DOI: 10.3389/fimmu.2024.1492672.
Zhu A, Chen Z, Yan Q, Jiang M, Liu X, Li Z Nat Immunol. 2025; 26(3):459-472.
PMID: 39875584 PMC: 11876067. DOI: 10.1038/s41590-024-02072-9.
Distinct CD8 T-cell types Associated with COVID-19 Severity in Unvaccinated HLA-A2 Patients.
Masuda K, Iketani S, Liu L, Huang J, Qiao Y, Shah J bioRxiv. 2025; .
PMID: 39868279 PMC: 11761488. DOI: 10.1101/2025.01.12.632164.